PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 411,000
-1,500 (-0.36%)
At close: Dec 4, 2025
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 4.27 trillion as of December 4, 2025. Its market cap has increased by 74.52% in one year.
Market Cap
4.27T
Enterprise Value
3.97T
Revenue
496.03B
Ranking
n/a
PE Ratio
28.22
Stock Price
411,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 4.27T, an increase of 323.10%. That is a compound annual growth rate of 14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 4.29T | 57.14% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | 552.15B | 60.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.33T |
| Celltrion | 40.65T |
| ALTEOGEN | 28.99T |
| ABL Bio | 10.85T |
| SK Biopharmaceuticals | 10.80T |
| Yuhan | 9.10T |
| Peptron | 7.40T |
| LigaChem Biosciences | 7.13T |